Next 10 |
home / stock / abio / abio articles
The Dow Jones index closed higher by more than 200 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concer...
Several stocks with high short interest rallied on Monday following an incredible surge in GameStop Corp (NYSE:GME) shares. Here’s a quick lo...
ARCA biopharma and Oruka Therapeutics announce Merger Agreement ARCA biopharma appoints Thomas Keuer as President WESTMINSTER, Colo., April 25,...
NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to th...
NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potenti...
NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potenti...
NEW YORK, April 05, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potenti...
Shares of STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong preliminary first-qua...
Shares of Flora Growth Corp. (NASDAQ: FLGC) fell sharply in today’s pre-market trading after the company reported the launch of proposed un...
News, Short Squeeze, Breakout and More Instantly...
ARCA biopharma Inc. Company Name:
ABIO Stock Symbol:
NASDAQ Market:
0.0% G/L:
$2.40 Last:
290,850 Volume:
$2.35 Open:
$2.40 Close:
ARCA biopharma Inc. Website:
2024-09-02 09:02:04 ET ARCA biopharma Inc (ABIO) announced stock split at a ratio of 1-for-12 on 2024-09-03 ... Full story available on KlickAnalytics.com
WESTMINSTER, Colo., Aug. 29, 2024 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (NASDAQ: ABIO) (“ARCA”) today announced completion of the merger with Oruka Therapeutics, Inc. (“Oruka”) following ARCA’s successful receipt of stockholder approval for all proposals rela...
WESTMINSTER, Colo., Aug. 26, 2024 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (NASDAQ: ABIO) (“ARCA”) today announced an update to the previously announced final amount of the special cash dividend (the “Special Dividend”), which will now equal $1.613 per share of ARCA...